KRKA, TOVARNA ZDRAVIL D.D. - Acquisition of treasury shares

Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:

1. Detailed report on acquisition of treasury shares.pdfDetailed report on acquisition of treasury shares
   

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 34 / 2024

Date of issue: 2024-07-19

Short name of the issuer

KRKA

Subject

Acquisition of treasury shares

Official market - legal basis

Unofficial market - legal basis

Contents of the report:

Based on the provisions of the Rules of the Ljubljana Stock Exchange, d. d., Ljubljana and Article 2 of the Commission Delegated Regulation (EU) 2016/1052 Krka, d. d., Novo mesto announces:

With a reference to the public notice from 20 July 2023, Krka is publicly disclosing information on transactions relating to buy-back programme in the period from 12 July 2024 up to and including 18 July 2024. Krka acquired 4,822 treasury shares in the total value of EUR 708,053 on the Ljubljana Stock Exchange as follows:

- on 12 July 2024: 1,121 shares at a VWAP of EUR 143.94,
- on 15 July 2024: 837 shares at a VWAP of EUR 144.17,
- on 16 July 2024: 1,075 shares at a VWAP of EUR 147.72,
- on 17 July 2024: 887 shares at a VWAP of EUR 149.36,
- on 18 July 2024: 902 shares at a VWAP of EUR 149.39.

Price is calculated as volume weighted average price (VWAP).
Ilirika d.d., Intercapital d.d. and NLB d.d. were brokers in these transactions. Detailed report on acquisition of treasury shares attached.

The total number of treasury shares prior to these transactions was 2,002,329 representing 6.106% of all shares issued.
The total number of treasury shares after these transactions is 2.007.151 representing 6.121% of all shares issued.

The notice will be published on the Company's website (www.krka.biz) from 19 July 2024 onwards, for a period of at least 5 years.

Annexes

File Description

Detailed report on acquisition of treasury shares.pdfDetailed report on acquisition of treasury shares.pdf Detailed report on acquisition of treasury shares

KRKA, TOVARNA ZDRAVIL D.D.

(fullname of the issuer)

KRKA Farmaceutyczny (far)

(short name of the issuer) (sector according to clasification of the WSE in Warsow)

8501 Nove Mesto

(post code) (city)

Smarjeska 6

(street) (number)

[phone] [phone]

(phone number) (fax)

(e-mail) (web site)

nie dotyczy

(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Date Name Position / Function Signature

2024-07-19 Jože Colarič President of the Management Board and CEO